Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
![Book bundle cover eBook and print](https://images.ctfassets.net/ahaoy9whsr8a/3hh8459sY2nXIBbSiKJFQm/ed36678e72516d39f8a78ab741be67ec/book-promo-banner3.png?fm=webp&w=400&q=75)
Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines serves as an introduction to the international regulatory arena in which biologicals are developed… Read more
Limited Offer
Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines serves as an introduction to the international regulatory arena in which biologicals are developed and offers an overview of the processes and insight into the scientific concepts underpinning global regulations.
In this new edition the book provides additional coverage of Quality by Design, Combination Products, Target Product Profiles, Quality Target Product Profiles, RiskMAPs, Additional pre-IND assignment, Switching from reliance on in vivo to in vitro analytical methods. It also reflects the new developments and processes accelerated by the COVID-19 vaccine experience. New pedagogic elements and case studies have been added to improve learning outcomes for students.
This book provides multiple levels of readership with guidance on basic concepts, a detailed look at regulatory challenges, and practical insight into how regulators consider regulatory science and regulatory process issues across various regions. Graduate students will benefit from the new pedagogic features. Regulatory professionals will have in Fundamentals of Biologicals Regulation: Vaccines and Biotechnology Medicines a complete guide to navigate through the approval process.
Graduate students or professionals studying regulatory affairs and regulatory science for a biology, biotechnology, or engineering Masters, Ph.D., or Certificate program, Biologics regulators in various countries who want to learn more about how other countries regulate similar products (particularly those in developing countries who want to learn about the US and EU processes), Developers of combination products or combined use systems (e.g., oncology products that are combined with a medical device, specifically an in vitro diagnostic).
RS
KZ
MS
SN
CH
IK